top of page

A painless dissolving microneedle patch

to treat chronic illnesses

  • Painless

  • Easy to use

  • No bio-hazardous waste

  • Thermostable

  • High loading: up to 90% API

Vitropep - stress free treatment for chronic illnesses.

Eliminate the stress of hypodermic injections.


Our goal is to create a world where illnesses are no longer barriers to leading fulfilling lives and critical treatments are accessible to all. We are building a future where our dissolving microneedle patches provide consistent, personalized treatment experiences. By combining science, compassion, and technology, we aspire to be at the forefront of health care advancements, fostering improved patient outcomes and reducing the pharmaceutical industry's environmental footprint.


Our mission is to transform health care by developing a painless, dissolving microneedle patch that empowers patients to manage chronic illnesses effectively in the comfort of their homes. We are committed to enhancing the quality of life by reducing the treatment burden and improving therapeutic outcomes for individuals suffering from acute or chronic illnesses. Through rigorous research, innovation, and collaboration, we aim to make a lasting impact on global health.

Dissolving microneedle patch to treat chronic illnesses

As a young startup, we are looking for commercial partners and potential investors.



Vitropep utilizes patent-pending technology to design painless dissolving microneedles that are versatile and optimized for the transdermal delivery of biomolecules. Our dissolving microneedles are made from an extensive collection of biomolecules, which gives us a competitive advantage. While our primary focus is on developing treatments for chronic illnesses, our versatility enables us to target various medical fields.

Vitropep Founder Christophe Tarabout in the lab
Vitropep - Pipetting samples

"Any sufficiently advanced technology is indistinguishable from magic."

Arthur C. Clarke




4 Rue Pierre Fontaine

91058 Évry-Courcouronnes


  • LinkedIn


bottom of page